Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients - PubMed (original) (raw)
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients
Masami Tanaka et al. PLoS One. 2009.
Abstract
Background: MicroRNAs are a family of 19- to 25-nucleotides noncoding small RNAs that primarily function as gene regulators. Aberrant microRNA expression has been described for several human malignancies, and this new class of small regulatory RNAs has both oncogenic and tumor suppressor functions. Despite this knowledge, there is little information regarding microRNAs in plasma especially because microRNAs in plasma, if exist, were thought to be digested by RNase. Recent studies, however, have revealed that microRNAs exist and escape digestion in plasma.
Methodology/principal findings: We performed microRNA microaray to obtain insight into microRNA deregulation in the plasma of a leukemia patient. We have revealed that microRNA-638 (miR-638) is stably present in human plasmas, and microRNA-92a (miR-92a) dramatically decreased in the plasmas of acute leukemia patients. Especially, the ratio of miR-92a/miR-638 in plasma was very useful for distinguishing leukemia patients from healthy body.
Conclusions/significance: The ratio of miR-92a/miR-638 in plasma has strong potential for clinical application as a novel biomarker for detection of leukemia.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Figure 1. Expression profiling of microRNAs in normal plasmas.
A. MicroRNA expression profiles in seven normal samples by microRNA microarray analysis. Y axis represents relative intensity of hybridization signals. B. Comparison of the signal intensities of various microRNAs among normal plasmas. The signal intensity of each microRNA by microarray analysis is evaluated as a rank order among the detected microRNAs. Y axis represents log10 (Rank of signal intensity in each sample/average rank of that in all samples).
Figure 2. Comparison of microRNA expressions in the plasmas of normal and acute leukemia.
A. Comparison of signal intensity ranks of various microRNAs in normal (n = 7) and leukemia (n = 2) plasmas by microarray analysis. Y axis represents mean ratio of the signal intensity rank of leukemia to the rank of normal of each microRNA. B. Comparison of the ratio of miR92a signal intensity to miR-638 signal intensity by _Taq_Man qRT-PCR among the plasmas of normal and leukemia. Mann-Whitney's U test was used to determine statistical significance.
Figure 3. MicroRNA expression in leukemic cells.
In situ hybridization was performed using LNA probes for miR-92a and negative control. Blue signals represent positive for the microRNAs. Bars indicate 50 µm.
Similar articles
- Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM, Mousa NO, Badawy MA, El Taweel MA, Osman A. Gado MM, et al. Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3625-3633. doi: 10.31557/APJCP.2019.20.12.3625. Asian Pac J Cancer Prev. 2019. PMID: 31870103 Free PMC article. - Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D, Lange-Turenhout EA, Stumpel DJ, Stam RW, Buijs-Gladdines JG, Meijerink JP, Pieters R, Den Boer ML. Schotte D, et al. Haematologica. 2010 Oct;95(10):1675-82. doi: 10.3324/haematol.2010.023481. Epub 2010 May 21. Haematologica. 2010. PMID: 20494936 Free PMC article. - [Preliminary analysis of aberrant expression of plasma miR-223 in pediatric acute lymphoblastic leukemia with a direct RT-PCR assay].
Lu XJ, Jiang Q, Huang PL, Li G, Zhang WJ, Zhao XX, Zheng HY. Lu XJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):68-72. doi: 10.7534/j.issn.1009-2137.2013.01.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 23484694 Chinese. - MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential.
Mardani R, Jafari Najaf Abadi MH, Motieian M, Taghizadeh-Boroujeni S, Bayat A, Farsinezhad A, Gheibi Hayat SM, Motieian M, Pourghadamyari H. Mardani R, et al. J Cell Physiol. 2019 Jun;234(6):8465-8486. doi: 10.1002/jcp.27776. Epub 2018 Dec 4. J Cell Physiol. 2019. PMID: 30515779 Review. - The emerging role of microRNA-22 in the Leukemia: experimental and clinical implications.
Xia J, Bu C, Zhang B, Wang X, Chen Y, Li T. Xia J, et al. Mol Biol Rep. 2023 Dec 12;51(1):12. doi: 10.1007/s11033-023-08922-3. Mol Biol Rep. 2023. PMID: 38085373 Review.
Cited by
- Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy.
Guarnieri L, Amodio N, Bosco F, Carpi S, Tallarico M, Gallelli L, Rania V, Citraro R, Leo A, De Sarro G. Guarnieri L, et al. Noncoding RNA. 2024 Mar 17;10(2):18. doi: 10.3390/ncrna10020018. Noncoding RNA. 2024. PMID: 38525737 Free PMC article. Review. - miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
Saadi MI, Nikandish M, Ghahramani Z, Valandani FM, Ahmadyan M, Hosseini F, Rahimian Z, Jalali H, Tavasolian F, Abdolyousefi EN, Kheradmand N, Ramzi M. Saadi MI, et al. J Egypt Natl Canc Inst. 2023 Jun 19;35(1):18. doi: 10.1186/s43046-023-00174-3. J Egypt Natl Canc Inst. 2023. PMID: 37332027 - Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules.
Alotaibi F. Alotaibi F. Front Genet. 2023 Feb 17;14:1052731. doi: 10.3389/fgene.2023.1052731. eCollection 2023. Front Genet. 2023. PMID: 36873941 Free PMC article. Review. - Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer.
He J, Wu J, Dong S, Xu J, Wang J, Zhou X, Rao Z, Gao W. He J, et al. J Oncol. 2023 Feb 16;2023:7335456. doi: 10.1155/2023/7335456. eCollection 2023. J Oncol. 2023. PMID: 36844871 Free PMC article. - Identification of differentially expressed genes induced by aberrant methylation in acute myeloid leukemia using integrated bioinformatics analyses.
Chen WW, Liu DB, Xiao HX, Zhou LJ, Qu J. Chen WW, et al. Oncol Lett. 2022 Sep 13;24(5):383. doi: 10.3892/ol.2022.13503. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36238356 Free PMC article.
References
- Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15 Spec No 1:R17–29. - PubMed
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
- He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–531. - PubMed
- Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563–568. - PubMed
- Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441–450. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical